| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics |
Department of Microbiology, Kumamoto University School of Medicine, Kumamoto 860-0811, Japan
Hydrogen peroxide (H2O2) is a strong oxidant that induces apoptosis of tumor cells in vitro. Here, we investigated the antitumor activity of an H2O2-generating enzyme, D-amino acid oxidase (DAO), and its conjugate with polyethylene glycol (PEG; PEG-DAO). Compared with DAO, PEG-DAO showed improved pharmacokinetic parameters in mice after i.v. injection. PEG-DAO administered i.v. accumulated selectively in tumor tissue with insignificant accumulation in normal organs and tissues. To generate cytotoxic H2O2 at the tumor site, PEG-DAO was first administrated i.v. to tumor-bearing mice. After an adequate lag time, the substrate of DAO, D-proline, was injected i.p. This treatment resulted in significant suppression of tumor growth compared with tumor growth in control animals (not given treatment; P < 0.001). Similar treatment with native DAO showed no effect under the same conditions. Oxidative metabolites were significantly increased in solid tumors by administration of PEG-DAO followed by D-proline (P < 0.002, compared with the group receiving no treatment), as evidenced by thiobarbituric acid-reactive substance assay. This treatment did not affect results from the metabolites in the liver and kidney. These findings suggest that tumor-targeted delivery of DAO is accomplished by using pegylated enzyme and thereby taking advantage of the enhanced permeability and retention effect in solid tumor. PEG-DAO thus delivered together with D-proline produces remarkable antitumor activity via extensive generation of H2O2.
This article has been cited by other articles:
![]() |
Z. Liu, C. Davis, W. Cai, L. He, X. Chen, and H. Dai Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy PNAS, February 5, 2008; 105(5): 1410 - 1415. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Park, Y. Shishido, S. Ichise-Shishido, T. Kawazoe, K. Ono, S. Iwana, Y. Tomita, K. Yorita, T. Sakai, and K. Fukui Potential Role for Astroglial D-Amino Acid Oxidase in Extracellular D-Serine Metabolism and Cytotoxicity J. Biochem., February 1, 2006; 139(2): 295 - 304. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nishikawa, S. Nishikawa, N. Akiyama, and S. Natori Correlation between the Catalase Level in Tumor Cells and Their Sensitivity to N-{beta}-Alanyl-5-S-Glutathionyl-3,4-Dihydroxyphenylalanine (5-S-GAD) J. Biochem., April 1, 2004; 135(4): 465 - 469. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Pelicano, L. Feng, Y. Zhou, J. S. Carew, E. O. Hileman, W. Plunkett, M. J. Keating, and P. Huang Inhibition of Mitochondrial Respiration: A NOVEL STRATEGY TO ENHANCE DRUG-INDUCED APOPTOSIS IN HUMAN LEUKEMIA CELLS BY A REACTIVE OXYGEN SPECIES-MEDIATED MECHANISM J. Biol. Chem., September 26, 2003; 278(39): 37832 - 37839. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. DeNardo, Z. Yao, K. S. Lam, A. Song, P. A. Burke, G. R. Mirick, K. R. Lamborn, R. T. O'Donnell, and G. L. DeNardo Effect of Molecular Size of Pegylated Peptide on the Pharmacokinetics and Tumor Targeting in Lymphoma-Bearing Mice Clin. Cancer Res., September 1, 2003; 9(10): 3854S - 3864. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Fang, T. Sawa, T. Akaike, T. Akuta, S. K. Sahoo, G. Khaled, A. Hamada, and H. Maeda In Vivo Antitumor Activity of Pegylated Zinc Protoporphyrin: Targeted Inhibition of Heme Oxygenase in Solid Tumor Cancer Res., July 1, 2003; 63(13): 3567 - 3574. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |